Filing Details

Accession Number:
0001209191-19-043930
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-31 21:15:50
Reporting Period:
2019-07-30
Accepted Time:
2019-07-31 21:15:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1438533 Retrophin Inc. RTRX Pharmaceutical Preparations (2834) 262383102
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1579649 L. Noah Rosenberg C/O Retrophin, Inc.
3721 Valley Centre Drive, Suite 200
San Diego CA 92130
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-07-30 1,250 $19.82 14,750 No 4 S Direct
Common Stock Disposition 2019-07-31 1,250 $20.07 13,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.